MannKind Corp
MNKD
$4.23
Share price
1.20%
Change (1 day)
8.74%
Change (1 year)
Categories
MannKind Corp (MNKD) - Total debt
Total debt on the balance sheet as of December 2023 : $0.27 B
According to MannKind Corp's latest financial reports the company's total debt is $0.27 B. A company’s total debt is the sum of all current and non-current debts.
MannKind Corp - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | -2.23% |
| 2022-12-31 | $0.27 B | -1.21% |
| 2021-12-31 | $0.28 B | 128.65% |
| 2020-12-31 | $0.12 B | 1.67% |
| 2019-12-31 | $0.12 B | 18.47% |
| 2018-12-31 | $0.10 B | -34.65% |
| 2017-12-31 | $0.15 B | 5.61% |
| 2016-12-31 | $0.14 B | -30.64% |
| 2015-12-31 | $0.21 B | -4.81% |
| 2014-12-31 | $0.22 B | -10.13% |
| 2013-12-31 | $0.25 B | -24.54% |
| 2012-12-31 | $0.33 B | -32.02% |
| 2011-12-31 | $0.48 B | 9.71% |
| 2010-12-31 | $0.44 B | 60.08% |
| 2009-12-31 | $0.27 B | 95.26% |
| 2008-12-31 | $0.14 B | 27.28% |
| 2007-12-31 | $0.11 B | 0.44% |
| 2006-12-31 | $0.11 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 25,886.34% | 🇺🇸 USA |
 Novo Nordisk NVO | $3.99 B | 1,367.10% | 🇩🇰 Denmark |
 Eli Lilly LLY | $25.22 B | 9,152.78% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 12,758.37% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.49 B | 449.93% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.11 B | -56.80% | 🇺🇸 USA |